Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2009 | 4 |
2010 | 1 |
2012 | 1 |
2013 | 1 |
2024 | 0 |
Search Results
7 results
Results by year
Filters applied: . Clear all
Page 1
The clinical impact of continuing to prescribe antiretroviral therapy in patients with advanced AIDS who manifest no virologic or immunologic benefit.
PLoS One. 2013 Nov 15;8(11):e78676. doi: 10.1371/journal.pone.0078676. eCollection 2013.
PLoS One. 2013.
PMID: 24260125
Free PMC article.
Clinical Trial.
Correlates of protective cellular immunity revealed by analysis of population-level immune escape pathways in HIV-1.
Carlson JM, Brumme CJ, Martin E, Listgarten J, Brockman MA, Le AQ, Chui CK, Cotton LA, Knapp DJ, Riddler SA, Haubrich R, Nelson G, Pfeifer N, Deziel CE, Heckerman D, Apps R, Carrington M, Mallal S, Harrigan PR, John M, Brumme ZL; International HIV Adaptation Collaborative.
Carlson JM, et al.
J Virol. 2012 Dec;86(24):13202-16. doi: 10.1128/JVI.01998-12. Epub 2012 Oct 10.
J Virol. 2012.
PMID: 23055555
Free PMC article.
Item in Clipboard
Phase I/II trial of the anti-HIV activity of mifepristone in HIV-infected subjects ACTG 5200.
Para MF, Schouten J, Rosenkranz SL, Yu S, Weiner D, Tebas P, White CJ, Reeds D, Lertora J, Patterson KB, Daar ES, Cavert W, Brizz B; ACTG A5200 Team of the ACTG.
Para MF, et al.
J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):491-5. doi: 10.1097/QAI.0b013e3181d142cb.
J Acquir Immune Defic Syndr. 2010.
PMID: 20130470
Free PMC article.
Clinical Trial.
Item in Clipboard
HLA-associated immune escape pathways in HIV-1 subtype B Gag, Pol and Nef proteins.
Brumme ZL, John M, Carlson JM, Brumme CJ, Chan D, Brockman MA, Swenson LC, Tao I, Szeto S, Rosato P, Sela J, Kadie CM, Frahm N, Brander C, Haas DW, Riddler SA, Haubrich R, Walker BD, Harrigan PR, Heckerman D, Mallal S.
Brumme ZL, et al.
PLoS One. 2009 Aug 19;4(8):e6687. doi: 10.1371/journal.pone.0006687.
PLoS One. 2009.
PMID: 19690614
Free PMC article.
Item in Clipboard
Low rate of CMV end-organ disease in HIV-infected patients despite low CD4+ cell counts and CMV viremia: results of ACTG protocol A5030.
Wohl DA, Kendall MA, Andersen J, Crumpacker C, Spector SA, Feinberg J, Alston-Smith B, Owens S, Chafey S, Marco M, Maxwell S, Lurain N, Jabs D, Benson C, Keiser P, Jacobson MA; A5030 Study Team.
Wohl DA, et al.
HIV Clin Trials. 2009 May-Jun;10(3):143-52. doi: 10.1310/hct1003-143.
HIV Clin Trials. 2009.
PMID: 19632953
Free PMC article.
Clinical Trial.
Item in Clipboard
Prevalence and persistence of cervical human papillomavirus infection in HIV-positive women initiating highly active antiretroviral therapy.
Fife KH, Wu JW, Squires KE, Watts DH, Andersen JW, Brown DR.
Fife KH, et al.
J Acquir Immune Defic Syndr. 2009 Jul 1;51(3):274-82. doi: 10.1097/QAI.0b013e3181a97be5.
J Acquir Immune Defic Syndr. 2009.
PMID: 19387354
Free PMC article.
Item in Clipboard
Predictive value of pharmacokinetics-adjusted phenotypic susceptibility on response to ritonavir-enhanced protease inhibitors (PIs) in human immunodeficiency virus-infected subjects failing prior PI therapy.
Eron JJ Jr, Park JG, Haubrich R, Aweeka F, Bastow B, Pakes GE, Yu S, Wu H, Richman DD; ACTG5126 Study Team.
Eron JJ Jr, et al.
Antimicrob Agents Chemother. 2009 Jun;53(6):2335-41. doi: 10.1128/AAC.01387-08. Epub 2009 Mar 23.
Antimicrob Agents Chemother. 2009.
PMID: 19307363
Free PMC article.
Clinical Trial.
Item in Clipboard
Cite
Cite